Home / Research Library / Cardiovascular, mortality, and kidney outcomes wit...
🧬 Medicine & Biology OpenAlex

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

📅 August 20, 2021 👤 Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen et al. 📖 The Lancet Diabetes & Endocrinology 📊 1,487 citations

🤖 Plain-English Summary

This research explores Cardiovascular, mortality, and kidney outcomes with GLP-1 re..., contributing new insights to the field of Medicine & Biology.

🔑 Key Findings

  • Research demonstrates significant advances in patient outcome data
  • Study provides new evidence regarding clinical efficacy results
  • Findings open new directions for biological mechanism insights

💡 Why This Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

Read the full paper
Access the original peer-reviewed research via OpenAlex.

View on DOI ↗

📋 Article Details

Category 🧬 Medicine & Biology
Published Aug 20, 2021
Journal The Lancet Diabetes & Endocrinology
Authors Naveed Sattar, Matthew M.Y. Lee, Søren Lund Kristensen, Kelley R. Branch, Stefano Del Prato
DOI 10.1016/s2213-8587(21)00203-5
Citations 1,487
Source OpenAlex

More 🧬 Medicine & Biology Research